Cinctive Capital Management LP Ginkgo Bioworks Holdings, Inc. Put Options Transaction History

Cinctive Capital Management LP

  • $1.72 Billion
  • Q3 2024

Put Options

3 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$0.73 - $3.74 $73,000 - $374,000
100,000 New
100,000 $312,000
Q2 2022

Aug 15, 2022
SELL
$2.2 - $4.2 $550,000 - $1.05 Million
-250,000 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$2.83 - $8.69 $707,500 - $2.17 Million
250,000 New
250,000 $1.01 Million

Others Institutions Holding DNA

# of Institutions
40
Shares Held
48.1M
Call Options Held
0
Put Options Held
0
View Full List

About Ginkgo Bioworks Holdings, Inc.

DNA Quotes by TradingView
  • Ticker DNA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,287,779,968
  • Market Cap $13.2B
  • Description
  • Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...
More about DNA
Track This Portfolio

Track Cinctive Capital Management LP Portfolio

Follow Cinctive Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cinctive Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Cinctive Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email